The Effects of Age and Smoking Upon Antipyrine Metabolism
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?.
Ozdemir V, Fourie J, Busto U, Naranjo C Clin Pharmacokinet. 1996; 31(5):372-85.
PMID: 9118585 DOI: 10.2165/00003088-199631050-00004.
Hepatic drug metabolism and aging.
Durnas C, Loi C, Cusack B Clin Pharmacokinet. 1990; 19(5):359-89.
PMID: 2268986 DOI: 10.2165/00003088-199019050-00002.
References
1.
OMalley K, Crooks J, Duke E, Stevenson I
. Effect of age and sex on human drug metabolism. Br Med J. 1971; 3(5775):607-9.
PMC: 1798743.
DOI: 10.1136/bmj.3.5775.607.
View
2.
ANDREASEN P, Vesell E
. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration. Clin Pharmacol Ther. 1974; 16(6):1059-65.
DOI: 10.1002/cpt19741661059.
View
3.
Vestal R, Norris A, Tobin J, Cohen B, SHOCK N, Andres R
. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther. 1975; 18(4):425-32.
DOI: 10.1002/cpt1975184425.
View
4.
Fraser H, Mucklow J, Murray S, Davies D
. Assessment of antipyrine kinetics by measurement in saliva. Br J Clin Pharmacol. 1976; 3(2):321-5.
PMC: 1428876.
DOI: 10.1111/j.1365-2125.1976.tb00610.x.
View
5.
Stevenson I
. Factors influencing antipyrine elimination. Br J Clin Pharmacol. 1977; 4(3):261-5.
PMC: 1429089.
DOI: 10.1111/j.1365-2125.1977.tb00710.x.
View